Skip to main content
. Author manuscript; available in PMC: 2011 Jul 4.
Published in final edited form as: Exp Neurol. 2007 Mar 7;210(2):295–307. doi: 10.1016/j.expneurol.2007.03.001

Table 1.

Description of experimental groups

Time after
injury
Groups Drug
delivery
n
(ELISA,
WB)
n
(H,IHC)
n
(BBB)
Total
24h Sham + Vehicle 1ul/hr for 24h 4 3 NA 7
Sham + Tat-Bcl-xL 10ug/day 4 NA 4
Injury + Vehicle 5 3 NA 8
Injury + Tat-Bcl-xL 5 3 NA 8

7days Sham + Vehicle 0.5ul/hr for 7 7 3 NA 10
Injury + Vehicle days 7 3 NA 10
Injury + Tat-Bcl-xL 5ug/day. 7 3 NA 10
Injury + Tat-BH4 7 3 NA 10

60 days Sham + Vehicle 0.5ul/hr for 7 3* 3 10 10
Injury + Vehicle days 3* 3 10 10
Injury + Tat-Bcl-xL 5ug/day. 3* 3 8# 10
Injury + Tat-BH4 3* 3 10 10

TOTAL 48 105
*

Only WB analysis but no Cell death ELISA was performed in this group.

#

An additional injury at the site of catheter implantation was observed at the time of perfusion in two Tat-Bcl-xL treated animals. Data from these animals were omitted from the analysis. n(ELISA, WB), number of animals for which apoptotic cell death was measured by ELISA and analysis of Bcl-xL levels were quantified by western blot. n(H, IHC), number of animals used for histology and immunohistochemistry analysis. n (BBB), number of animals for which BBB scores were obtained. NA, Not applicable